RAYMOND JAMES & ASSOCIATES – Abbott Laboratories Transaction History
RAYMOND JAMES & ASSOCIATES portfolio value:
$306.49M
portfolio value
RAYMOND JAMES & ASSOCIATES quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +8.02% | 235.29K shares | -12.09M | $96.76 | 3.16M |
| Q2 2022 | share | Decrease | -3.12% | -94.39K shares | -39.64M | $108.65 | 2.93M |
| Q1 2022 | share | Increase | +0.87% | 26.02K shares | -64.07M | $118.36 | 3.02M |
| Q4 2021 | share | Increase | +5.09% | 145.21K shares | 85M | $141 | 3.00M |
| Q3 2021 | share | Increase | +3.79% | 104.33K shares | 18.37M | $117.68 | 2.85M |
| Q2 2021 | share | Increase | +4.53% | 119.15K shares | 3.52M | $115.05 | 2.75M |
| Q1 2021 | share | Increase | +10.88% | 258.21K shares | 55.51M | $118.49 | 2.63M |
| Q4 2020 | share | Increase | +13.35% | 279.60K shares | 31.99M | $107.81 | 2.37M |
| Q3 2020 | share | Decrease | -0.52% | -11.01K shares | 35.43M | $106.81 | 2.09M |
| Q2 2020 | share | Increase | +2.97% | 60.62K shares | 31.14M | $89.39 | 2.10M |
| Q1 2020 | share | Increase | +0.36% | 7.24K shares | -15.62M | $76.84 | 2.04M |
| Q4 2019 | share | Increase | +2.69% | 53.28K shares | 10.95M | $84.23 | 2.03M |
| Q3 2019 | share | Increase | +2.59% | 50.12K shares | 3.36M | $80.81 | 1.98M |
| Q2 2019 | share | Decrease | -4.41% | -89.31K shares | 907K | $80.92 | 1.93M |
| Q1 2019 | share | Decrease | -4.58% | -97.21K shares | 8.36M | $76.6 | 2.02M |
| Q4 2018 | share | Increase | +1.60% | 33.48K shares | 273K | $68.98 | 2.12M |
| Q3 2018 | share | Increase | +5.14% | 101.95K shares | 32.03M | $69.69 | 2.08M |
| Q2 2018 | call | Decrease | -100.00% | -30.5K shares | -20K | $57.68 | 0 |
| Q2 2018 | share | Increase | +7.14% | 132.33K shares | 10.05M | $57.68 | 1.98M |
| Q1 2018 | share | Decrease | -4.28% | -82.88K shares | 549K | $56.4 | 1.85M |
| Q1 2018 | call | Increase | +8.54% | 2.4K shares | 5K | $56.4 | 30.5K |
| Q4 2017 | call | Decrease | -54.90% | -34.2K shares | -88K | $53.46 | 28.1K |
| Q4 2017 | share | Decrease | -17.56% | -412.24K shares | -14.81M | $53.46 | 1.93M |
| Q3 2017 | share | Increase | +2.47% | 56.65K shares | 13.90M | $49.74 | 2.34M |
| Q3 2017 | call | Increase | +5.77% | 3.4K shares | -133K | $49.74 | 62.3K |
| Q2 2017 | share | Increase | +10.98% | 226.59K shares | 19.68M | $45.07 | 2.29M |
| Q2 2017 | call | Decrease | -7.10% | -4.5K shares | 232K | $45.07 | 58.9K |
| Q1 2017 | share | Increase | +15.33% | 274.46K shares | 22.92M | $40.93 | 2.06M |
| Q1 2017 | call | Increase | +6.38% | 3.8K shares | 3K | $40.93 | 63.4K |
| Q4 2016 | share | Increase | +0.11% | 1.93K shares | -6.86M | $35.17 | 1.79M |
| Q4 2016 | call | Decrease | -58.67% | -84.6K shares | -159K | $35.17 | 59.6K |
| Q3 2016 | call | Increase | 0.00% | 144.2K shares | 160K | $38.48 | 144.2K |
| Q3 2016 | share | Increase | +17.51% | 266.40K shares | 15.80M | $38.48 | 1.78M |
| Q2 2016 | share | Increase | +7.17% | 101.86K shares | 426K | $35.55 | 1.52M |
| Q1 2016 | share | Decrease | -4.94% | -73.73K shares | -7.68M | $37.6 | 1.41M |